Guideline / position statementindependent cross-checkabstract checked I-SOD-102 standard review

Diet drinks: short-term substitute, not a long-term goal

Health Effects of Sugar-Sweetened and Artificially Sweetened Beverages: Umbrella Review and Evidence-Based Consensus Statement of the Korean Diabetes Association and the Korean Nutrition Society.

Overview

Choi JH et al.. Diabetes Metab J 2026 · PMID 41531289 · DOI 10.4093/dmj.2025.0848

Korean experts found that swapping sugary drinks for diet drinks lowered weight slightly in trials, but long-term observational links to disease mean water is the better goal.

Does the study support the specific claim? Partly · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Give evidence-based advice on sugary and diet drinks.

How was the study done?

Meta-analysis of trials plus review of cohort reviews.

How many people, animals or samples were studied?

14 trials and 20 reviews.

What was actually found?

Swapping lowered weight by 0.73 kg; long-term cohort links for both drink types.

How large was the observed effect?

-0.73 kg body weight.

What do the results mean in everyday life?

Diet drinks can help people cut sugary drinks, but water is best.

What are the study's limitations?

Consensus; abstract reviewed.

What does it say about Elawady's specific claim?

Partly supports 'diet soda is not a safe alternative'.

Do the results apply to Germany and Europe?

Applicable in principle.

What can explicitly not be concluded from this study?

Cannot settle whether sweeteners cause disease.

Scientific in-depth review

1. Full reference

Authors
Choi JH et al.
Journal
Diabetes Metab J
Year
2026
Identifier
PMID 41531289 DOI 10.4093/dmj.2025.0848
Verification
verified – PubMed efetch 2026-10-26 + Crossref 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Not stated in abstract record

2. Research question

What are the benefits and harms of SSB and ASB, and should ASB replace SSB?

3. Study design and population

Study design
Guideline / position statement – Consensus statement based on an updated RCT meta-analysis (14 RCTs) and an umbrella review of 20 systematic reviews of cohorts
Population

Adults

Country

Korea (international evidence)

Period

2025-2026

Sample size

14 RCTs (3-76 weeks); 20 systematic reviews of cohorts

Inclusion and exclusion criteria

RCTs replacing SSB with ASB; cohort reviews of long-term outcomes

4. Methods and endpoints

Exposure / intervention

ASB replacing SSB; habitual SSB and ASB

Comparator

SSB; low intake

Endpoints

Body weight, body fat, glycaemic/cardiometabolic markers; T2D, CVD, mortality

Statistical methods

Meta-analysis of RCTs; umbrella review

5. Actual results

Results

Replacing SSB with ASB reduced body weight (-0.73 kg) and body fat (-0.72%), with inconsistent effects on glycaemic and cardiometabolic markers. Cohort reviews (up to 34 years) showed higher SSB and ASB intakes associated with increased T2D, CVD and mortality risk, with relative risks for ASB similar to SSB.

Absolute risks

not reported

Authors' conclusion

ASB may serve as a short-term substitute for people with high SSB intake; regular or long-term use not recommended; water and unsweetened beverages should be the goal.

6. Strengths

  • Combines RCT and cohort evidence
  • Professional-society consensus
  • Recent (2026)

7. Weaknesses

  • Consensus process; abstract only reviewed
  • Korean focus of recommendations

8. Risk of bias

Orienting tool
none applicable
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
not assessable
Rationale

Consensus statement; methods not appraised in detail.

9. Assessment of the statistical interpretation

RCT benefit is short- to intermediate-term; cohort ASB risks may reflect confounding.

10. Relevance to the specific claim

Mixed for C-SOD-10: agrees that diet soda is not a long-term health solution, but shows short-term benefit when replacing sugary soda.

11. Independent contrary findings

McGlynn 2022 (I-SOD-103).

12. Transferability to Germany and Europe

Evidence international; recommendations national.

13. Overall methodological judgement

Balanced recent position consistent with WHO 2023 and ADA 2026.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biasnot assessable
Precision of resultsmoderate
Directnessdirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Long-term RCTs.

15. Linked fact checks